All good things must eventually come to an end, and so it is withATL's Ultramark 4 ultrasound scanner. After a 12-year run in whichover 12,000 systems were installed, the Bothell, WA, company hasdiscontinued U.S. production of the workhorse ob/gyn
All good things must eventually come to an end, and so it is withATL's Ultramark 4 ultrasound scanner. After a 12-year run in whichover 12,000 systems were installed, the Bothell, WA, company hasdiscontinued U.S. production of the workhorse ob/gyn scanner.
ATL introduced Ultramark 4 in 1984 as a general-purpose, non-color-flowscanner. Sales of the systems were shifted to ob/gyn physiciansand international markets as the vendor developed more advancedscanners. The scanner sold for $30,000 to $60,000, depending onconfiguration.
U.S. production of Ultramark 4 was stopped early this year,although manufacturing and sales will continue in India throughATL's joint venture company in that country.
A major factor contributing to the scanner's demise was thechanging face of the U.S. market, which has resulted in fewersolo ob/gyn practitioners and more group practices that can affordmore advanced technology, according to ATL spokesperson Jane Hedberg.
"We feel that the ob/gyn market is going to more of agroup practice situation," Hedberg said. "Ultramark4 was a very successful product for us, but the technology hasimproved since then and it is time to provide more image qualityand more features."
While the entire ATL sales force sold Ultramark 4 scanners,the majority of sales were handled by a 15-person ob/gyn salesteam. Those employees will be folded into a new sales force ATLhas established, which is targeted at women's health.
To fill Ultramark 4's place in the gray-scale imaging segment,ATL is rolling out an upgraded version of the Apogee 800 scanner,which the company acquired through its purchase of Interspec.Apogee 800 Plus features a new user-friendly control panel, anew microprocessor, and new and expanded analysis packages, Hedbergsaid. It will begin shipping next month at list prices of $65,000for a gray-scale scanner to $90,000 for a color version.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.